| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2134938 | Experimental Hematology | 2009 | 11 Pages |
Abstract
Our data suggest that reduction in the proportion of γδ T cells and granzyme B gene polymorphism leads to defective immune function in breast cancer patients. Treatment with zoledronic acid amend partially this fault. Further studies of γδ T cells function and granzyme B gene polymorphism in cancers, as well as the potential therapeutic use of zoledronic acid are warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ameera Gaafar, Mahmoud Deeb Aljurf, Abdullah Al-Sulaiman, Alia Iqniebi, Pulicat S. Manogaran, Gamal Eldin H. Mohamed, Adher Al-Sayed, Hazaa Alzahrani, Fahad Alsharif, Fahad Mohareb, Dahish Ajarim, Abdelghani Tabakhi, Khalid Al-Hussein,